Lymphoma, Non-Hodgkin
Showing NaN - NaN of 21
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- JCAR017
- +7 more
-
Duarte, California
- +17 more
Jan 13, 2023
Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Standard of Care
- JCAR017
-
Phoenix, Arizona
- +78 more
Jan 13, 2023
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin, Lymphoma, B-Cell Trial in United States (lisocabtagene maraleucel)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +3 more
- lisocabtagene maraleucel
-
Gilbert, Arizona
- +40 more
Apr 22, 2022
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Lymphoma, B-Cell
- +4 more
-
Burbank, California
- +90 more
Mar 31, 2022
Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)
Recruiting
- Lymphoma, Non-Hodgkin
- +9 more
- NKX019
-
Denver, Colorado
- +6 more
Jan 19, 2022
Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)
Completed
- Lymphoma, Non-Hodgkin
- Hematopoietic Stem Cell Transplant
-
Duarte, California
- +20 more
Dec 7, 2021
Lymphoma, Non-Hodgkin, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +9 more
-
Los Angeles, California
- +21 more
Oct 26, 2021
Lymphoma, Non-Hodgkin Trial in Worldwide (pixantrone, cyclophosphamide, vincristine, rituximab, prednisone, Vinorelbine,
Completed
- Lymphoma, Non-Hodgkin
- pixantrone, cyclophosphamide, vincristine, rituximab, prednisone
- Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab
-
Fountain Valley, California
- +98 more
Jan 27, 2020
Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)
Completed
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Non-Hodgkin
- brentuximab vedotin
-
Birmingham, Alabama
- +21 more
Feb 2, 2017
Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Canada, United States (brentuximab vedotin,
Completed
- Lymphoma, B-Cell
- +3 more
- brentuximab vedotin
- rituximab
-
Birmingham, Alabama
- +33 more
Oct 14, 2016
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)
Terminated
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- SGN-40
- +5 more
-
Birmingham, Alabama
- +65 more
Feb 6, 2015
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in United States (SGN-40)
Completed
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
-
Birmingham, Alabama
- +13 more
Dec 17, 2014
Lymphoma, Non-Hodgkin Trial in Worldwide (Taxane (Cytotoxic, BAY59-8862))
Completed
- Lymphoma, Non-Hodgkin
- Taxane (Cytotoxic, BAY59-8862)
-
Miami Beach, Florida
- +22 more
Oct 10, 2013
Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- Recombinant Human Interleukin-2 and Rituximab
-
Tucson, Arizona
- +32 more
Feb 2, 2006
Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- Recombinant Human Interleukin-2 and Rituximab
-
Little Rock, Arkansas
- +64 more
Feb 2, 2006